About IOB’s founding partners

University of Basel

The University of Basel is proud to be Switzerland’s oldest university. Over the centuries, it has evolved to become an internationally respected, regionally integrated research university with an extensive curriculum that enjoys an excellent position within the life sciences and other disciplines. Well-respected rankings attest to the University of Basel’s outstanding academic performance. The Basel region is one of the most successful life science clusters in the world. Naturally, we also want to belong to the world’s best research institutions in this field. At the same time, the University of Basel strives to create knowledge in all kinds of disciplines for the benefit of society.

University Hospital Basel

The University Hospital Basel is one of the five university hospitals in Switzerland and the largest healthcare centre in the North-Western region of the country. With around 8,000 employees from more than 80 nations, it is one of the region’s largest employers and provides medical care for patients both locally and internationally. The hospital treats roughly 40,000 inpatients per year while also delivering comprehensive outpatient services across all medical fields. The University Hospital Basel enjoys close ties with the University of Basel’s Medical Faculty and collaborates with regional life sciences partners to advance scientific research and innovation. These connections help foster the highest standards of clinical care, research and education. Covering a full spectrum of medicine through interdisciplinary clinics and research groups, the University Hospital Basel continually contributes to improving healthcare outcomes and translating scientific discoveries into patient-centered practice.

Novartis

Novartis is a Swiss multinational pharmaceutical company headquartered in Basel, Switzerland, with roots tracing back through the legacies of Ciba-Geigy and Sandoz to more than 150 years of innovation in medicine. As a major employer and key contributor to the region’s life sciences ecosystem, Novartis is committed to reimagining medicine to improve and extend people’s lives. The company works to empower patients, healthcare professionals and communities by delivering innovative treatments for serious diseases across multiple therapeutic areas. Novartis focuses on developing and bringing to market breakthrough medicines in fields such as oncology, immunology, neuroscience and cardiovascular health, while continuing to invest heavily in research and development to address unmet medical needs globally. Its products reach hundreds of millions of patients each year, and the company operates in more than 140 countries worldwide.